Christopher J. Ocampo
Allergy and Immunology
676 N Saint Clair St Ste 14019
Chicago, IL 60611
Chicago, IL 60611
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pharmacokinetic profiling of limnetrelvir in non-Japanese and Japanese populations: results of two phase 1 single- and multiple-dose studies.
Journal: Antimicrobial agents and chemotherapy
Published: March 23, 2026
Pharmacokinetic Drug Interaction Studies of Limnetrelvir with Midazolam and Itraconazole in Healthy Participants.
Journal: Clinical drug investigation
Published: August 01, 2025
Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors.
Journal: Cancer medicine
Published: October 29, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.
Journal: Investigational new drugs
Published: January 09, 2020
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
Journal: Journal of neuro-oncology
Published: April 24, 2019
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Journal: Cancer
Published: November 28, 2017
Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
Journal: The Journal of allergy and clinical immunology
Published: March 03, 2016
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
Journal: American journal of respiratory and critical care medicine
Published: June 13, 2015
Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity.
Journal: The Journal of allergy and clinical immunology
Published: July 11, 2013
Medical therapy as the primary modality for the management of chronic rhinosinusitis.
Journal: Allergy and asthma proceedings
Published: March 15, 2013
Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.
Journal: American journal of rhinology & allergy
Published: February 15, 2013
Last Updated: 09/26/2026